Product logins

Find logins to all Clarivate products below.


Facial Injectables | Asia Pacific | 2014 | Market Analysis

Valued at $588 million in 2013, the Asia Pacific market for facial injectables will be among the most rapidly growing global markets over the next ten years, expanding to reach a value of over $1.8 billion by 2022.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables (including botulinum toxins and dermal fillers) in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Aesthetic Injectables – Market Insights – Europe
The European aesthetic injectable market is on a strong growth trajectory. Product innovation and differentiated offerings from leading companies are expected to propel this expansion. The…
Report
Aesthetic Injectables – Market Insights – North America
The North American aesthetic injectable market is poised for sustained growth through 2034, driven by ongoing innovation and strong consumer demand. Leading global manufacturers continue to invest…
Report
Sports Medicine Devices – Market Insights – Asia Pacific
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, and improved surgeon training will drive rapid growth in the Asia Pacific…